SMTL ID : 8eo2.1 (1 other biounit)

Lufaxin a bifunctional inhibitor of complement and coagulation

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 8 residues within 4Å: Chain A: N.40, T.42, H.43, V.45, Q.80, V.92, M.220 Ligands: BR.6 3 PLIP interactions: 3 interactions with chain A Water bridges: A:Q.80, A:K.90 Hydrophobic interactions: A:V.92 Hydrogen bonds: A:Q.80

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 11 residues within 4Å: Chain A: Y.5, F.6, I.7, S.71, T.74, R.75, N.76, L.77, H.163, N.165, G.166 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:T.74, A:N.76, A:L.77, A:L.77, A:G.166 Water bridges: A:F.6, A:S.71, A:N.165, A:N.165

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 8 residues within 4Å: Chain A: N.232, G.233, E.234, C.235, N.239, T.241, C.242, E.243 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.232, A:E.234, A:E.243

3 x BR: BROMIDE ION(Non-covalent)

BR.4: 3 residues within 4Å: Chain A: K.117, R.185, E.186 Ligand excluded by PLIP BR.5: 4 residues within 4Å: Chain A: S.115, F.116, D.118, R.119 Ligand excluded by PLIP BR.6: 3 residues within 4Å: Chain A: K.90 Ligands: NAG-NAG-BMA.1, NAG-NAG-BMA.1 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Andersen, J.F. et al., A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism. Blood (2023)

Release Date

2023-08-09

Peptides

Lufaxin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Lufaxin

Related Entries With Identical Sequence